Latest Parkinson Stories
Free program includes expert talks about research and therapies. Cleveland, OH (PRWEB) September 21, 2012 University Hospitals (UH) Neurological Institute’s
Researchers have taken a step toward personalized medicine for Parkinson's disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments.
23andMe, Inc., a leading personal genetics company, has announced the first-time discovery of the potentially protective nature of the gene serum/glucocorticoid regulated kinase 1 (SGK1) which appears to be protective against a high-risk leucine-rich repeat kinase 2 (LRRK2) mutation for Parkinson’s disease (PD).
- A woman chauffeur.
- A woman who operates an automobile.